{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:36:11Z","timestamp":1776915371269,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,27]],"date-time":"2027-03-27T00:00:00Z","timestamp":1806105600000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI060354"],"award-info":[{"award-number":["P30 AI060354"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008548","name":"Harvard T H Chan School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008548","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007301","name":"Harvard University Center for AIDS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU38PS004651"],"award-info":[{"award-number":["NU38PS004651"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.annepidem.2026.110079","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:05:04Z","timestamp":1773763504000},"page":"110079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: A comparison of behavioral, acquisition-risk based, and economic metrics"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9292-5670","authenticated-orcid":false,"given":"Minttu M.","family":"R\u00f6nn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena P.","family":"Kourtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Lin A.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupa R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen W.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Van Handel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas A.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2026.110079_bib1","unstructured":"Centers for Disease Control. Estimated HIV incidence and prevalence in the United States, 2018\u20132022. \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/156513\u3009."},{"key":"10.1016\/j.annepidem.2026.110079_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110079_bib3","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2026.110079_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/QAD.0b013e328344fe4a","article-title":"Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm","volume":"25","author":"Fox","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.annepidem.2026.110079_bib5","first-page":"2203","article-title":"Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement","volume":"321","author":"Owens","year":"2019"},{"key":"10.1016\/j.annepidem.2026.110079_bib6","unstructured":"Centers for Disease Control. Clinical Guidance for PrEP. \u3008https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html\u3009."},{"key":"10.1016\/j.annepidem.2026.110079_bib7","article-title":"Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis","volume":"33","author":"Sullivan","year":"2024","journal-title":"Lancet Reg Health"},{"key":"10.1016\/j.annepidem.2026.110079_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","article-title":"The prevalence of PrEP use and the PrEP-to-need ratio in the fourth quarter of 2017, United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2026.110079_bib9","unstructured":"Centers for Disease Control and Prevention. Preventing New HIV Infections, Guidelines and Recommendations. \u3008https:\/\/www.cdc.gov\/hiv\/guidelines\/preventing.html\u3009."},{"key":"10.1016\/j.annepidem.2026.110079_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2023.14461","article-title":"Preexposure prophylaxis to prevent acquisition of HIV: US preventive services task force recommendation statement","volume":"330","author":"Barry","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2026.110079_bib11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.annepidem.2018.05.003","article-title":"Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race\/ethnicity, United States, 2015","volume":"28","author":"Smith","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2026.110079_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25461","article-title":"National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017","volume":"23","author":"Sullivan","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.annepidem.2026.110079_bib13","unstructured":"Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition and Examination Survey Data. \u3008https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/default.aspx\u3009."},{"key":"10.1016\/j.annepidem.2026.110079_bib14","unstructured":"Centers for Disease Control and Prevention (CDC). National center for health statistics (NCHS). National Survey of Family Growth. Preprint at \u3008https:\/\/www.cdc.gov\/nchs\/nsfg\/index.htm\u3009."},{"key":"10.1016\/j.annepidem.2026.110079_bib15","unstructured":"U.S. Census Bureau. American community survey. https:\/\/www.census.gov\/programs-surveys\/acs."},{"key":"10.1016\/j.annepidem.2026.110079_bib16","doi-asserted-by":"crossref","DOI":"10.2196\/publichealth.5365","article-title":"Estimating the population sizes of men who have sex with men in US states and counties using data from the American community survey","volume":"2","author":"Grey","year":"2016","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.annepidem.2026.110079_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cid\/ciac543","article-title":"Estimated number of people who inject drugs in the United States","volume":"76","author":"Bradley","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110079_bib18","article-title":"HIV Infection, risk, prevention, and testing behaviors among persons who inject drugs:National HIV behavioral surveillance","volume":"23","author":"Centers for Disease Control and Prevention","year":"2018","journal-title":"Inject Drug Use"},{"key":"10.1016\/j.annepidem.2026.110079_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13263","article-title":"Receptive anal sex contributes substantially to heterosexually acquired HIV infections among at-risk women in twenty US cities: results from a modelling analysis","volume":"84","author":"Elmes","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.annepidem.2026.110079_bib20","unstructured":"Centers for Disease Control and Prevention. NCHHSTP AtlasPlus. Updated 2017. \u3008https:\/\/www.cdc.gov\/nchhstp\/atlas\/index.htm\u3009."},{"key":"10.1016\/j.annepidem.2026.110079_bib21","first-page":"238","article-title":"Lifetime risk of a diagnosis of HIV infection in the United States","volume":"27","author":"Hess","year":"2017"},{"key":"10.1016\/j.annepidem.2026.110079_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002973","article-title":"Opioid agonist treatment scale-up and the initiation of injection drug use: a dynamic modeling analysis","volume":"16","author":"Marks","year":"2019","journal-title":"PLOS Med"},{"key":"10.1016\/j.annepidem.2026.110079_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40273-017-0494-4","article-title":"Bayesian methods for calibrating health policy models: a tutorial","volume":"35","author":"Menzies","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.annepidem.2026.110079_bib24","first-page":"209","article-title":"Methods of measuring the concentration of wealth","volume":"9","author":"Lorenz","year":"1905","journal-title":"Publ Am Stat Assoc"},{"key":"10.1016\/j.annepidem.2026.110079_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jadohealth.2019.07.022","article-title":"Cost-effectiveness of pre-exposure prophylaxis among adolescent sexual minority males","volume":"66","author":"Wang","year":"2020","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.annepidem.2026.110079_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-156-8-201204170-00001","article-title":"The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men","volume":"156","author":"Juusola","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annepidem.2026.110079_bib27","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/QAI.0b013e3182a5c8d4","article-title":"Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era","volume":"64","author":"Farnham","year":"2013","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annepidem.2026.110079_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness \u2014 the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2026.110079_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.annepidem.2025.04.017","article-title":"Estimating the population need for preexposure prophylaxis for HIV in the United States","volume":"106","author":"Kourtis","year":"2025","journal-title":"Ann Epidemiol"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:41:20Z","timestamp":1776912080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279726000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"alternative-id":["S1047279726000773"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110079","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: A comparison of behavioral, acquisition-risk based, and economic metrics","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110079"}}